Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Bristol-Myers Squibb
Celgene
Celgene
University of California, Davis
French Innovative Leukemia Organisation
Kirby Institute
University of Birmingham
Celgene
Yale University
National Institutes of Health Clinical Center (CC)
Celgene
Celgene
Celgene